Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML.
Saved in:
| Title: | Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML. |
|---|---|
| Authors: | Murdock HM; Division of Hematologic Neoplasia, Department of Medical Oncology, and., Kim HT; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Denlinger N; Division of Hematology, The Ohio State University James Cancer Hospital, Columbus, OH., Vachhani P; Division of Hematology and Oncology, University of Alabama at Birmingham School of Medicine, Birmingham, AL., Hambley B; Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH., Manning BS; Department of Medicine, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA., Gier S; Department of Medicine, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA., Cho C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Tsai HK; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA., McCurdy S; Department of Medicine, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA., Ho VT; Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Koreth J; Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Soiffer RJ; Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ritz J; Division of Hematologic Neoplasia, Department of Medical Oncology, and., Carroll MP; Department of Medicine, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA., Vasu S; Division of Hematology, The Ohio State University James Cancer Hospital, Columbus, OH., Perales MA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Wang ES; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Gondek LP; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD., Devine S; National Marrow Donor Program, Minneapolis, MN; and., Alyea EP; Duke Cancer Institute, Duke University Medical Center, Durham, NC., Lindsley RC; Division of Hematologic Neoplasia, Department of Medical Oncology, and., Gibson CJ; Division of Hematologic Malignancies, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. |
| Source: | Blood [Blood] 2022 Jun 16; Vol. 139 (24), pp. 3546-3557. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
